Screening for attention-deficit/hyperactivity disorder in borderline personality disorder.

Related Articles

Screening for attention-deficit/hyperactivity disorder in borderline personality disorder.

J Affect Disord. 2017 Sep 23;226:85-91

Authors: Weibel S, Nicastro R, Prada P, Cole P, Rüfenacht E, Pham E, Dayer A, Perroud N

Abstract
BACKGROUND: A valid screening instrument is needed to detect attention-deficit/hyperactivity disorder (ADHD) in treatment-seeking borderline personality disorder (BPD) patients. We aimed to test the performance of the widely-used Adult ADHD Self-Report Scale v1.1 screener (ASRS-v1.1).
METHODS: 317 BPD subjects were systematically assessed for comorbid ADHD and completed the ASRS-v1.1. 79 BPD patients also completed the Wender Utah Rating Scale (WURS-25).
RESULTS: The prevalence of adult ADHD was of 32.4%. The overall positive predictive value of the ASRS-v1.1 was of 38.5%, the negative predictive value 77.0%, the sensitivity 72.8%, and the specificity 43.9%. Combining WURS-25 and ASRS-v1.1 improved sensitivity to 81.8% and specificity to 59.6%.
LIMITATIONS: Cross-sectional study on treatment-seeking patients.
CONCLUSIONS: We found a high prevalence of ADHD using structured interviews. The ASRS-v1.1 was not a sensitive screener for identifying possible ADHD cases in a BPD population, with a high number of false positives. When combined with the WURS-25, it offered improved screening.

PMID: 28964997 [PubMed – as supplied by publisher]

via https://www.ncbi.nlm.nih.gov/pubmed/28964997?dopt=Abstract